
  
    
      
        Background_NNP
        Many_RB cloned_VBN animals_NNS have_VBP been_VBN created_VBN using_VBG M_NNP II_NNP oocytes_NNS
        as_IN the_DT recipient_JJ cytoplasm_NN (_( sheep_NN [_NN 1_CD ,_, 2_CD ]_NN ,_, cattle_NNS [_NN 3_CD ,_, 4_CD ,_,
        5_CD ]_NN ,_, mouse_NN [_NN 6_CD ,_, 7_CD ]_NN ,_, goat_NN [_NN 8_CD ]_NN and_CC pig_NN [_NN 9_CD ,_, 10_CD ,_, 11_CD ]_NN )_) ._.
        Maturation_NNP /_NN meiosis_NNS /_NN mitosis-promoting_JJ factor_NN (_( MPF_NNP )_) activity_NN
        of_IN recipient_JJ M_NNP II_NNP oocytes_NNS appears_VBZ to_TO be_VB important_JJ for_IN the_DT
        reprogramming_VBG of_IN nuclei_NN of_IN reconstructed_VBD embryos_NNS ._. Two_CD
        distinct_JJ and_CC different_JJ protocols_NNS emerge_VBP for_IN embryo_NN
        reconstruction_NN by_IN nuclear_JJ transfer_NN when_WRB using_VBG M_NNP II_NNP oocytes_NNS
        as_IN recipients_NNS ._. The_DT first_JJ is_VBZ the_DT transfer_NN of_IN nuclei_NN in_IN G_NNP 1_CD ,_, S_NNP
        or_CC G_NNP 2_CD phase_NN into_IN the_DT preactivated_JJ recipients_NNS after_IN reducing_VBG
        MPF_NNP activity_NN and_CC the_DT second_NN is_VBZ the_DT transfer_NN of_IN nuclei_NN in_IN GO_NNP
        or_CC G_NNP 1_CD phase_NN directly_RB into_IN M_NNP II_NNP oocytes_NNS having_VBG high_JJ MPF_NNP
        activity_NN [_NN 12_CD ]_NN ._. Recently_RB ,_, it_PRP has_VBZ been_VBN shown_VBN that_IN when_WRB mouse_NN
        embryonic_JJ stem_NN cells_NNS [_NN 13_CD ]_NN and_CC bovine_JJ somatic_JJ cells_NNS [_NN 14_CD ]_NN
        in_IN the_DT M_NNP phase_NN were_VBD transferred_VBN into_IN non-treated_JJ
        recipients_NNS ,_, the_DT chromosome_NN constitution_NN of_IN reconstructed_VBD
        embryos_NNS was_VBD normal_JJ in_IN that_IN the_DT second_JJ polar_JJ body_NN was_VBD
        excluded_VBN after_IN parthenogenetic_JJ activation_NN and_CC the_DT embryos_NNS
        developed_VBN to_TO offspring_NN ._. The_DT first_JJ protocol_NN is_VBZ effective_JJ for_IN
        production_NN of_IN blastomeres_NNS derived_VBN cloned_VBN embryos_NNS because_IN
        cell_NN cycle_NN synchronization_NN of_IN embryonic_JJ nuclei_NN is_VBZ difficult_JJ
        and_CC the_DT majority_NN of_IN blastomeres_NNS are_VBP in_IN the_DT S_NNP phase_NN at_IN any_DT
        given_VBN time_NN [_NN 15_CD ,_, 16_CD ,_, 17_CD ]_NN ._. In_IN the_DT preactivated_JJ oocyte_NN ,_, the_DT
        nuclear_JJ membrane_NN of_IN the_DT donor_NN cells_NNS remains_VBZ intact_JJ due_NN to_TO
        the_DT low_JJ activity_NN of_IN MPF_NNP and_CC DNA_NNP synthesis_NN occurs_VBZ according_VBG
        to_TO the_DT original_JJ cell_NN cycle_NN stage_NN at_IN the_DT time_NN of_IN nuclear_JJ
        transfer_NN [_NN 12_CD ]_NN and_CC nuclear_JJ reprogramming_VBG occurs_VBZ during_IN the_DT
        expansion_NN of_IN the_DT donor_NN nucleus_NN [_NN 18_CD ,_, 19_CD ]_NN ._. Additionally_RB ,_,
        nuclei_NN of_IN cells_NNS of_IN established_VBN embryonic_JJ cell_NN lines_NNS are_VBP
        reprogrammed_JJ in_IN preactivated_JJ recipient_JJ oocytes_NNS ,_, porcine_NN
        embryos_NNS reconstituted_JJ with_IN blastocyst-derived_JJ cells_NNS and_CC
        preactivated_JJ recipients_NNS have_VBP the_DT ability_NN to_TO develop_VB to_TO
        blastocysts_NNS [_NN 20_CD ]_NN ._. However_RB ,_, there_EX is_VBZ only_RB one_CD report_NN in_IN
        which_WDT cloned_VBN animals_NNS have_VBP been_VBN produced_VBN from_IN embryos_NNS
        reconstructed_VBN by_IN transferring_VBG differentiated_JJ cells_NNS into_IN
        preactivated_JJ recipient_JJ oocytes_NNS [_NN 8_CD ]_NN and_CC the_DT ability_NN of_IN
        preactivated_JJ recipient_JJ oocytes_NNS to_TO reprogram_NN differentiated_JJ
        cells_NNS is_VBZ now_RB in_IN debate_NN ._. When_WRB bovine_JJ somatic_JJ cells_NNS were_VBD
        transferred_VBN into_IN preactivated_JJ recipient_JJ oocytes_NNS ,_, the_DT
        resulting_VBG reconstructed_VBN embryo_NN development_NN was_VBD limited_JJ ,_,
        since_IN all_DT embryos_NNS arrested_VBN at_IN the_DT 8_CD -_: cell_NN stage_NN regardless_RB
        of_IN the_DT cell_NN cycle_NN of_IN the_DT donor_NN cells_NNS [_NN 14_CD ]_NN ._. Because_IN
        embryonic_JJ genome_NN activation_NN of_IN bovine_JJ embryos_NNS occurs_VBZ
        between_IN the_DT 8_CD -_: to_TO 16_CD -_: cell_NN stages_NNS [_NN 21_CD ]_NN ,_, preactivated_JJ
        recipients_NNS may_MD not_RB reprogram_NN somatic_JJ nuclei_NN ._. In_IN contrast_NN ,_,
        when_WRB nuclei_NN in_IN G_NNP 0_CD or_CC G_NNP 1_CD phase_NN are_VBP transferred_VBN into_IN
        non-treated_JJ recipients_NNS ,_, reconstructed_VBD embryos_NNS can_MD develop_VB
        to_TO offspring_NN in_IN many_JJ species_NNS [_NN 1_CD ,_, 2_CD ,_, 3_CD ,_, 4_CD ,_, 5_CD ,_, 6_CD ,_, 8_CD ,_, 9_CD ,_, 10_CD ,_,
        11_CD ]_NN ._. In_IN the_DT M_NNP II_NNP oocyte_NN ,_, the_DT membrane_NN of_IN the_DT donor_NN nucleus_NN
        is_VBZ broken_VBN down_RB and_CC the_DT chromosomes_NNS are_VBP prematurely_RB
        condensed_JJ due_NN to_TO the_DT high_JJ activity_NN of_IN MPF_NNP ._. After_IN
        parthenogenetic_JJ activation_NN ,_, the_DT membrane_NN reforms_NNS and_CC DNA_NNP
        synthesis_NN begins_VBZ [_NN 22_CD ]_NN ._. MPF_NNP activity_NN during_IN oocyte_NN
        maturation_NN is_VBZ maximal_NN at_IN both_DT M_NNP I_PRP and_CC M_NNP II_NNP [_NN 12_CD ]_NN ._. Because_IN
        many_JJ studies_NNS suggest_VBP that_DT exposure_NN to_TO high_JJ activity_NN of_IN MPF_NNP
        is_VBZ effective_JJ for_IN reprogramming_VBG a_DT donor_NN nucleus_NN from_IN a_DT
        differentiated_JJ cell_NN [_NN 1_CD ,_, 2_CD ,_, 3_CD ,_, 4_CD ,_, 5_CD ,_, 6_CD ,_, 7_CD ,_, 8_CD ,_, 9_CD ,_, 10_CD ,_, 11_CD ,_,
        14_CD ]_NN ,_, M_NNP I_PRP oocytes_NNS may_MD reprogram_NN somatic_JJ cell_NN nuclei_NN as_RB well_RB ._.
        In_IN the_DT amphibian_NN ,_, the_DT greatest_JJS yield_NN and_CC most_JJS advanced_VBN
        tadpoles_NNS came_VBD from_IN differentiated_JJ somatic_JJ cell_NN nuclei_NN
        injected_VBN into_IN M_NNP I_PRP oocytes_NNS [_NN 23_CD ,_, 24_CD ]_NN compared_VBN to_TO M_NNP II_NNP
        oocytes_NNS [_NN 23_CD ,_, 25_CD ,_, 26_CD ]_NN ,_, although_IN adults_NNS could_MD not_RB be_VB
        generated_VBN from_IN these_DT reconstructed_VBN embryos_NNS ._. However_RB ,_, there_EX
        are_VBP no_DT reports_NNS that_WDT experimentally_RB tested_VBD this_DT hypothesis_NNS
        in_IN mammals_NNS ._. In_IN the_DT present_JJ study_NN ,_, we_PRP examined_VBD the_DT ability_NN
        of_IN porcine_NN M_NNP I_PRP oocytes_NNS to_TO reprogram_NN somatic_JJ cell_NN
        nuclei_NN ._.
      
      
        Results_NNS
        
          Cell_NNP Cycle_NNP Analysis_NNP of_IN Donor_NNP Cells_NNP
          The_DT cell_NN cycle_NN stages_NNS of_IN ear_NN fibroblasts_NNS after_IN
          reaching_VBG confluence_NN or_CC treatment_NN with_IN nocodazole_NN were_VBD
          analyzed_VBN using_VBG flow_NN cytometry_NN ._. Analysis_NNP of_IN the_DT cell_NN cycle_NN
          stages_NNS in_IN confluent_NN cells_NNS revealed_VBD that_DT 91_CD ._. 2_LS ±_NN 0_CD ._. 2_CD %_NN of_IN
          the_DT cells_NNS were_VBD at_IN the_DT G_NNP 0_CD /_NN G_NNP 1_CD phase_NN ,_, 2_CD ._. 5_CD ±_NN 0_CD ._. 1_CD %_NN were_VBD at_IN the_DT
          S_NNP phase_NN and_CC 6_CD ._. 4_CD ±_NN 0_CD ._. 1_CD %_NN were_VBD at_IN the_DT G_NNP 2_CD /_NN M_NNP phase_NN ._. In_IN the_DT
          population_NN of_IN cells_NNS collected_VBN after_IN nocodazole_NN treatment_NN ,_,
          31_CD ._. 0_CD ±_NN 3_CD ._. 6_CD %_NN were_VBD at_IN the_DT G_NNP 0_CD /_NN G_NNP 1_CD phase_NN ,_, 14_CD ._. 8_CD ±_NN 3_CD ._. 1_CD %_NN were_VBD at_IN
          the_DT S_NNP phase_NN and_CC 54_CD ._. 1_LS ±_NN 4_CD ._. 4_CD %_NN were_VBD at_IN the_DT G_NNP 2_CD /_NN M_NNP phase_NN ._.
          Experiments_NNS were_VBD repeated_VBN 3_CD times_NNS and_CC the_DT data_NNS are_VBP
          expressed_VBN as_IN mean_NN ±_NN SEM_NNP ._.
        
        
          Behaviour_NNP before_IN Activation_NNP of_IN Donor_NNP Cell_NNP
          Nuclei_NNP
          When_WRB confluent_NN cells_NNS were_VBD transferred_VBN into_IN M_NNP I_PRP
          oocytes_NNS ,_, the_DT fusion_NN rate_NN (_( 60_CD ._. 2_LS %_NN )_) was_VBD significantly_RB (_( P_NN
          <_NN 0_CD ._. 05_CD )_) higher_JJR than_IN that_DT (_( 25_CD ._. 8_CD %_NN )_) of_IN embryos_NNS
          reconstituted_JJ with_IN nocodazole-treated_JJ cells_NNS and_CC M_NNP I_PRP
          oocytes_NNS (_( Table_NNP 1_LS )_) ._. At_IN 15_CD h_NN after_IN fusion_NN ,_, spots_NNS of_IN
          condensed_JJ chromatin_NN (_( Figure_NN 1_CD Aand_NNP 1_CD B_NNP )_) were_VBD observed_VBN in_IN
          the_DT majority_NN (_( 85_CD ._. 0_CD %_NN )_) of_IN embryos_NNS reconstructed_VBN by_IN
          transferring_VBG confluent_NN cells_NNS and_CC this_DT percentage_NN was_VBD
          significantly_RB (_( P_NN <_NN 0_CD ._. 05_CD )_) higher_JJR than_IN that_DT (_( 63_CD ._. 3_LS %_NN )_) of_IN
          embryos_NNS reconstituted_JJ with_IN nocodazole-treated_JJ cells_NNS ._. When_WRB
          nocodazole-treated_JJ cells_NNS were_VBD transferred_VBN into_IN M_NNP I_PRP
          oocytes_NNS ,_, one_CD spot_NN of_IN condensed_JJ chromatin_NN and_CC one_CD polar_JJ
          body_NN (_( Figure_NN 1_CD C_NNP )_) was_VBD observed_VBN in_IN 13_CD ._. 3_LS %_NN of_IN reconstructed_VBD
          embryos_NNS ._. Regardless_RB of_IN the_DT cell_NN cycle_NN of_IN the_DT donor_NN cells_NNS ,_,
          the_DT percentage_NN (_( 3_CD ._. 3_LS -_: 5_CD ._. 0_CD %_NN )_) of_IN embryos_NNS with_IN swollen_JJ nuclei_NN
          (_( Figure_NN 1_CD Dand_NNP 1_CD E_NNP )_) was_VBD low_JJ ._.
        
        
          Behaviour_NNP after_IN Activation_NNP of_IN Donor_NNP Cell_NNP
          Nuclei_NNP
          As_IN shown_VBN in_IN Table_NNP 2_CD ,_, when_WRB confluent_NN cells_NNS were_VBD used_VBN as_IN
          donors_NNS ,_, the_DT fusion_NN rate_NN (_( 60_CD ._. 2_LS -_: 62_CD ._. 7_CD %_NN )_) was_VBD significantly_RB (_( P_NN
          <_NN 0_CD ._. 05_CD )_) higher_JJR than_IN that_DT (_( 29_CD ._. 0_CD -_: 33_CD ._. 6_CD %_NN )_) of_IN
          nocodazole-treated_JJ cells_NNS regardless_RB of_IN the_DT maturation_NN
          stage_NN of_IN the_DT recipient_JJ oocytes_NNS ._. At_IN 6_CD h_NN after_IN activation_NN ,_,
          swollen_JJ nuclei_NN were_VBD observed_VBN in_IN 50_CD ._. 0_CD and_CC 88_CD ._. 9_CD %_NN of_IN embryos_NNS
          produced_VBN by_IN transferring_VBG confluent_NN cells_NNS into_IN M_NNP I_PRP or_CC M_NNP II_NNP
          oocytes_NNS with_IN no_DT significant_JJ differences_NNS ._. Although_IN
          34_CD ._. 4_LS -_: 39_CD ._. 5_LS %_NN of_IN embryos_NNS reconstituted_JJ with_IN
          nocodazole-treated_JJ cells_NNS had_VBD swollen_JJ nuclei_NN ,_, the_DT
          percentage_NN of_IN embryos_NNS with_IN both_DT the_DT swollen_JJ nucleus_NN and_CC
          polar_JJ body_NN (_( Figure_NN 1_CD F_NN )_) was_VBD only_RB 6_CD ._. 3_CD -_: 10_CD ._. 5_LS %_NN ._.
        
        
          Development_NNP of_IN Reconstructed_NNP Embryos_NNP
          The_DT cleavage_NN rate_NN (_( 38_CD ._. 2_LS %_NN )_) of_IN embryos_NNS reconstituted_JJ
          with_IN confluent_NN cells_NNS and_CC M_NNP II_NNP oocytes_NNS was_VBD significantly_RB
          (_( P_NN <_NN 0_CD ._. 05_CD )_) higher_JJR than_IN that_DT (_( 5_CD ._. 3_LS -_: 9_CD ._. 7_CD %_NN )_) of_IN embryos_NNS
          produced_VBN by_IN transferring_VBG confluent_NN or_CC nocodazole-treated_JJ
          cells_NNS into_IN M_NNP I_PRP oocytes_NNS (_( Table_NNP 3_LS )_) ._. However_RB ,_, this_DT
          percentage_NN (_( 38_CD ._. 2_LS %_NN )_) did_VBD not_RB significantly_RB differ_VB from_IN that_DT
          of_IN embryos_NNS reconstituted_JJ with_IN nocodazole-treated_JJ cells_NNS
          and_CC M_NNP II_NNP oocytes_NNS (_( 15_CD ._. 4_LS %_NN )_) ._. When_WRB embryos_NNS reconstituted_JJ with_IN
          confluent_NN cells_NNS and_CC M_NNP I_PRP oocytes_NNS were_VBD cultured_JJ ,_, 2_CD (_( 1_CD ._. 5_LS %_NN )_)
          blastocysts_NNS (_( Figure_NN 2_LS )_) were_VBD obtained_VBN and_CC this_DT percentage_NN
          was_VBD significantly_RB (_( P_NN <_NN 0_CD ._. 05_CD )_) lower_JJR than_IN that_DT of_IN
          embryos_NNS produced_VBN by_IN transferring_VBG confluent_NN cells_NNS into_IN M_NNP
          II_NNP oocytes_NNS (_( 7_CD ._. 6_CD %_NN )_) ._. There_EX were_VBD no_DT significant_JJ differences_NNS
          in_IN mean_NN numbers_NNS of_IN cells_NNS in_IN the_DT blastocysts_NNS between_IN
          different_JJ maturation_NN stages_NNS of_IN the_DT recipient_JJ oocytes_NNS ._. No_DT
          embryos_NNS developed_VBN to_TO the_DT blastocyst_NN stage_NN when_WRB
          nocodazole-treated_JJ cells_NNS were_VBD used_VBN as_IN donors_NNS regardless_RB
          of_IN the_DT maturation_NN stage_NN of_IN the_DT recipient_JJ oocytes_NNS ._.
        
      
      
        Discussion_NNP
        The_DT results_NNS of_IN the_DT present_JJ study_NN demonstrated_VBD the_DT in_IN
        vitro_NN developmental_NN ability_NN to_TO blastocysts_NNS of_IN porcine_NN
        embryos_NNS reconstituted_JJ with_IN somatic_JJ cells_NNS and_CC enucleated_JJ M_NNP I_PRP
        oocytes_NNS ._. To_TO our_PRP$ knowledge_NN ,_, this_DT is_VBZ the_DT first_JJ report_NN that_WDT
        describes_VBZ blastocyst_NN formation_NN of_IN embryos_NNS reconstituted_JJ
        with_IN M_NNP I_PRP oocytes_NNS in_IN mammals_NNS ._.
        When_WRB donor_NN nuclei_NN are_VBP transferred_VBN into_IN non-treated_JJ M_NNP II_NNP
        recipient_JJ oocytes_NNS that_WDT have_VBP high_JJ MPF_NNP activity_NN ,_, various_JJ
        changes_NNS referred_VBD to_TO as_IN nuclear_JJ remodeling_NN occur_VB in_IN the_DT
        introduced_VBN nuclei_NN ._. This_DT phenomenon_NN is_VBZ considered_VBN to_TO involve_VB
        nuclear_JJ structural_JJ changes_NNS ,_, such_JJ as_IN nuclear_JJ envelope_NN
        breakdown_NN ,_, premature_JJ chromosome_NN condensation_NN and_CC pronuclear_NN
        development_NN and_CC swelling_VBG [_NN 27_CD ,_, 28_CD ,_, 29_CD ]_NN ._. Nuclear_NNP remodeling_VBG
        is_VBZ thought_VBN to_TO be_VB a_DT result_NN of_IN the_DT exchange_NN of_IN proteins_NNS
        between_IN the_DT nuclear_JJ and_CC cytoplasmic_JJ compartments_NNS [_NN 30_CD ]_NN and_CC
        is_VBZ pre-requisite_JJ to_TO or_CC is_VBZ part_NN of_IN the_DT reprogramming_VBG of_IN gene_NN
        expression_NN [_NN 31_CD ,_, 32_CD ,_, 33_CD ]_NN ._. Therefore_RB ,_, it_PRP is_VBZ generally_RB
        considered_VBN that_IN the_DT phenomenon_NN of_IN nuclear_JJ swelling_VBG is_VBZ one_CD
        essential_JJ component_NN of_IN the_DT more_RBR complex_JJ process_NN of_IN genetic_JJ
        reprogramming_VBG [_NN 34_CD ]_NN ._. In_IN the_DT present_JJ study_NN ,_, when_WRB confluent_NN
        or_CC nocodazole-treated_JJ cells_NNS were_VBD transferred_VBN into_IN
        enucleated_JJ M_NNP I_PRP oocytes_NNS ,_, nuclear_JJ swelling_VBG was_VBD observed_VBN in_IN
        34_CD ._. 4_LS -_: 50_CD ._. 0_CD %_NN of_IN reconstructed_VBD embryos_NNS after_IN activation_NN ._. This_DT
        result_NN suggests_VBZ that_DT porcine_NN M_NNP I_PRP oocytes_NNS can_MD initiate_VB
        reprogramming_VBG of_IN both_DT confluent_NN and_CC nocodazole-treated_JJ
        cells_NNS ._. Moreover_RB ,_, some_DT reconstructed_VBD embryos_NNS produced_VBN by_IN
        transferring_VBG confluent_NN cells_NNS developed_VBN to_TO the_DT blastocyst_NN
        stage_NN ._. Because_IN activation_NN of_IN the_DT embryonic_JJ genome_NN occurs_VBZ by_IN
        the_DT 4_CD -_: cell_NN stage_NN in_IN the_DT pig_NN [_NN 21_CD ]_NN ,_, it_PRP is_VBZ evident_JJ that_DT donor_NN
        nuclei_NN were_VBD at_IN least_JJS partially_RB reprogrammed_JJ in_IN these_DT
        blastocysts_NNS ._. Therefore_RB ,_, our_PRP$ results_NNS clearly_RB indicate_VBP that_DT
        porcine_NN M_NNP I_PRP oocytes_NNS like_IN M_NNP II_NNP oocytes_NNS have_VBP the_DT ability_NN to_TO
        reprogram_NN confluent_NN somatic_JJ cell_NN nuclei_NN as_IN determined_VBN by_IN
        nuclear_JJ remodeling_NN and_CC in_IN vitro_NN development_NN ._.
        The_DT blastocyst_NN formation_NN rate_NN of_IN reconstructed_VBD embryos_NNS
        produced_VBN by_IN transferring_VBG confluent_NN cells_NNS into_IN M_NNP I_PRP oocytes_NNS
        was_VBD significantly_RB lower_JJR than_IN that_DT of_IN embryos_NNS reconstituted_JJ
        with_IN confluent_NN cells_NNS and_CC M_NNP II_NNP oocytes_NNS although_IN there_EX were_VBD
        no_DT significant_JJ differences_NNS in_IN percentages_NNS of_IN embryos_NNS with_IN
        swollen_JJ nuclei_NN between_IN different_JJ maturation_NN stages_NNS of_IN
        recipient_JJ oocytes_NNS ._. These_DT results_NNS suggest_VBP that_IN the_DT
        reprogramming_VBG of_IN donor_NN nuclei_NN may_MD be_VB started_VBN but_CC is_VBZ not_RB
        completed_VBN in_IN some_DT embryos_NNS reconstituted_JJ with_IN M_NNP I_PRP oocytes_NNS ._.
        It_PRP has_VBZ been_VBN suggested_VBN that_IN nuclear_JJ swelling_VBG may_MD not_RB
        necessarily_RB be_VB a_DT sufficient_JJ indicator_NN of_IN developmental_NN
        potential_JJ in_IN a_DT reconstructed_VBN embryo_NN [_NN 28_CD ]_NN ._. In_IN addition_NN to_TO
        MPF_NNP ,_, mitogen-activated_JJ protein_NN (_( MAP_NNP )_) kinase_NN is_VBZ also_RB known_VBN
        as_IN an_DT important_JJ protein_NN kinase_NN that_WDT regulates_VBZ the_DT meiotic_JJ
        cell_NN cycle_NN [_NN 35_CD ]_NN ._. In_IN mouse_NN oocytes_NNS ,_, MAP_NNP kinase_NN plays_VBZ a_DT more_RBR
        important_JJ role_NN in_IN controlling_VBG chromatin_NN and_CC microtubule_NN
        behavior_NN than_IN MPF_NNP [_NN 36_CD ]_NN ._. However_RB ,_, MAP_NNP kinase_NN and_CC MPF_NNP
        activities_NNS do_VBP not_RB vary_VB between_IN M_NNP I_PRP and_CC M_NNP II_NNP of_IN porcine_NN
        oocytes_NNS because_IN phosphorylations_NNS of_IN MAP_NNP kinase_NN and_CC histone_NN
        H_NNP 1_CD kinase_NN which_WDT corresponds_NNS to_TO MPF_NNP activity_NN reach_VBP the_DT peak_NN
        level_NN at_IN M_NNP I_PRP and_CC remain_VB high_JJ beyond_IN M_NNP II_NNP [_NN 37_CD ,_, 38_CD ]_NN ._.
        Potentially_NNP ,_, an_DT unknown_JJ factor_NN (_( s_VBZ )_) is_VBZ required_VBN for_IN
        reprogramming_VBG of_IN nuclei_NN ,_, which_WDT is_VBZ present_JJ in_IN M_NNP II_NNP oocytes_NNS
        but_CC may_MD not_RB be_VB present_JJ or_CC active_JJ in_IN M_NNP I_PRP oocytes_NNS ._. It_PRP is_VBZ
        known_VBN that_DT pronuclear_NN exchange_NN between_IN zygotes_NNS does_VBZ not_RB
        prevent_VB development_NN of_IN the_DT reconstructed_VBN embryos_NNS [_NN 39_CD ]_NN but_CC
        transfer_NN of_IN donor_NN nuclei_NN from_IN later_RB developmental_NN stages_NNS
        into_IN enucleated_JJ zygotes_NNS brings_VBZ about_IN restricted_VBN development_NN
        [_NN 40_CD ,_, 41_CD ]_NN ._. One_CD explanation_NN of_IN this_DT phenomenon_NN is_VBZ that_IN a_DT
        factor_NN (_( s_VBZ )_) required_VBN for_IN reprogramming_VBG of_IN donor_NN nuclei_NN is_VBZ
        removed_VBN with_IN the_DT pronuclei_NN from_IN recipient_JJ zygotes_NNS ._.
        Similarly_RB ,_, the_DT factor_NN (_( s_VBZ )_) would_MD be_VB present_JJ near_IN the_DT
        chromosomes_NNS at_IN M_NNP I_PRP and_CC removed_VBN with_IN the_DT M_NNP I_PRP plate_NN during_IN
        enucleation_NN in_IN many_JJ oocytes_NNS ._. In_IN contrast_NN ,_, the_DT factor_NN (_( s_VBZ )_) is_VBZ
        believed_VBN to_TO be_VB in_IN cytoplasts_NNS derived_VBN from_IN M_NNP II_NNP oocytes_NNS
        because_IN embryos_NNS reconstituted_JJ with_IN donor_NN nuclei_NN from_IN later_RB
        developmental_NN stages_NNS and_CC enucleated_JJ M_NNP II_NNP oocytes_NNS can_MD
        develop_VB to_TO adults_NNS [_NN 42_CD ]_NN ._. An_DT alternative_NN cause_NN is_VBZ the_DT effect_NN
        of_IN cytochalasin_NN B_NNP ,_, a_DT microfilament_NN polymerization_NN
        inhibitor_NN ._. In_IN the_DT present_JJ study_NN ,_, reconstructed_VBD embryos_NNS
        produced_VBN by_IN transferring_VBG confluent_NN cells_NNS into_IN M_NNP I_PRP oocytes_NNS
        were_VBD cultured_JJ in_IN the_DT maturation_NN medium_NN supplemented_JJ with_IN
        cytochalasin_NN B_NNP to_TO prevent_VB loss_NN of_IN chromosomes_NNS by_IN polar_JJ body_NN
        formation_NN ._. However_RB ,_, it_PRP has_VBZ been_VBN reported_VBN recently_RB that_IN
        morphologically_RB normal_JJ M_NNP I_PRP spindles_NNS are_VBP formed_VBN but_CC further_JJ
        meiotic_JJ progression_NN does_VBZ not_RB occur_VB in_IN porcine_NN oocytes_NNS
        matured_VBN in_IN a_DT cytochalasin_NN B-_NNP containing_VBG medium_NN [_NN 38_CD ]_NN ._.
        Therefore_RB ,_, it_PRP is_VBZ possible_JJ that_IN reprogramming_VBG of_IN nuclei_NN
        transferred_VBN into_IN M_NNP I_PRP oocytes_NNS is_VBZ inhibited_VBD by_IN cytochalasin_NN
        B_NNP ._. Thirdly_NNP ,_, M_NNP I_PRP and_CC M_NNP II_NNP oocytes_NNS may_MD differ_VB in_IN cytoplasmic_JJ
        competence_NN ._. When_WRB porcine_NN M_NNP I_PRP oocytes_NNS are_VBP inseminated_JJ with_IN
        spermatozoa_NN in_IN vitro_NN ,_, the_DT formation_NN rate_NN of_IN male_JJ and_CC female_JJ
        pronuclei_NN is_VBZ significantly_RB lower_JJR than_IN that_DT in_IN M_NNP II_NNP oocytes_NNS
        [_NN 43_CD ]_NN ._. Finally_RB ,_, optimal_NN conditions_NNS for_IN activation_NN may_MD vary_VB
        between_IN M_NNP I_PRP and_CC M_NNP II_NNP oocytes_NNS ._. To_TO our_PRP$ knowledge_NN ,_, there_EX are_VBP
        no_DT reports_NNS that_WDT describe_VBP activation_NN of_IN MI_NNP oocytes_NNS in_IN
        mammals_NNS ._. Parameters_NNP of_IN the_DT activation_NN pulse_NN used_VBN in_IN the_DT
        present_JJ study_NN were_VBD also_RB optimized_JJ in_IN a_DT preliminary_JJ
        experiment_NN using_VBG M_NNP II_NNP oocytes_NNS ._. It_PRP is_VBZ possible_JJ that_DT
        optimization_NN of_IN methods_NNS for_IN activation_NN improves_VBZ the_DT
        development_NN of_IN embryos_NNS reconstituted_JJ with_IN M_NNP I_PRP oocytes_NNS ._.
        In_IN contrast_NN ,_, no_DT reconstructed_VBD embryos_NNS developed_VBN to_TO the_DT
        blastocyst_NN stage_NN regardless_RB of_IN the_DT maturation_NN stage_NN of_IN the_DT
        recipient_JJ oocytes_NNS when_WRB nocodazole-treated_JJ cells_NNS were_VBD
        transferred_VBN ,_, although_IN nuclear_JJ swelling_VBG was_VBD observed_VBN in_IN
        34_CD ._. 4_LS -_: 39_CD ._. 5_LS %_NN of_IN the_DT embryos_NNS ._. When_WRB cells_NNS in_IN M_NNP phase_NN are_VBP used_VBN
        as_IN donors_NNS ,_, reconstructed_VBD embryos_NNS with_IN a_DT polar_JJ body_NN are_VBP
        diploid_NN but_CC embryos_NNS without_IN a_DT polar_JJ body_NN are_VBP tetraploid_NN [_NN
        14_CD ]_NN ._. In_IN the_DT present_JJ study_NN ,_, the_DT percentage_NN of_IN embryos_NNS with_IN
        both_DT a_DT swollen_JJ nucleus_NN and_CC a_DT polar_JJ body_NN was_VBD low_JJ after_IN
        transfer_NN of_IN nocodazole-treated_JJ cells_NNS ._. In_IN the_DT bovine_JJ ,_, the_DT
        potential_NN of_IN reconstructed_VBD embryos_NNS with_IN or_CC without_IN the_DT
        polar_JJ body_NN to_TO develop_VB to_TO the_DT blastocyst_NN stage_NN is_VBZ not_RB
        different_JJ [_NN 14_CD ]_NN ._. However_RB ,_, this_DT study_NN suggests_VBZ that_DT porcine_NN
        tetraploid_NN embryos_NNS may_MD not_RB develop_VB to_TO blastocysts_NNS ._.
        In_IN the_DT present_JJ study_NN ,_, there_EX was_VBD a_DT significant_JJ difference_NN
        in_IN fusion_NN rates_NNS between_IN the_DT cell_NN cycles_NNS of_IN donor_NN cells_NNS ._. The_DT
        plasma_NN membrane_NN of_IN nocodazole-treated_JJ cells_NNS was_VBD weak_JJ
        compared_VBN to_TO that_DT of_IN confluent_NN cells_NNS and_CC many_JJ cells_NNS were_VBD
        broken_VBN before_IN and_CC after_IN applying_VBG a_DT fusion_NN pulse_NN ._. Parameters_NNP
        of_IN the_DT fusion_NN pulse_NN were_VBD optimized_JJ in_IN a_DT preliminary_JJ
        experiment_NN using_VBG confluent_NN cells_NNS ._. Therefore_RB ,_, it_PRP is_VBZ expected_VBN
        that_IN optimal_NN conditions_NNS for_IN fusion_NN vary_VBP among_IN cell_NN cycles_NNS
        of_IN donor_NN cells_NNS in_IN the_DT pig_NN ._.
        In_IN general_JJ ,_, in_IN vitro_NN maturation_NN (_( IVM_NNP )_) media_NNS used_VBN to_TO
        prepare_VB recipient_JJ oocytes_NNS for_IN production_NN of_IN cloned_VBN embryos_NNS
        are_VBP usually_RB supplemented_JJ with_IN fetal_JJ calf_NN serum_NN (_( FCS_NNP )_) [_NN 3_CD ,_,
        4_CD ,_, 5_CD ,_, 14_CD ]_NN or_CC porcine_NN follicular_NN fluid_JJ (_( pFF_NN )_) [_NN 11_CD ,_, 20_CD ,_, 44_CD ]_NN ._.
        It_PRP is_VBZ a_DT well_RB known_VBN fact_NN that_IN growth_NN factors_NNS and_CC hormones_NNS ,_,
        in_IN addition_NN to_TO many_JJ other_JJ factors_NNS ,_, are_VBP abundant_JJ in_IN serum_NN [_NN
        45_CD ,_, 46_CD ]_NN and_CC follicular_NN fluid_JJ [_NN 45_CD ,_, 47_CD ,_, 48_CD ]_NN ._. Therefore_RB ,_,
        supplementation_NN of_IN IVM_NNP media_NNS with_IN FCS_NNP or_CC pFF_NN presents_VBZ the_DT
        potential_JJ problems_NNS in_IN proper_JJ quality_NN control_NN and_CC
        repeatability_NN among_IN laboratories_NNS or_CC replicates_NNS ._. Recently_RB ,_, a_DT
        defined_VBN IVM_NNP system_NN for_IN porcine_NN oocytes_NNS was_VBD developed_VBN in_IN
        order_NN to_TO eliminate_VB such_JJ variability_NN [_NN 49_CD ,_, 50_CD ]_NN ._. In_IN the_DT
        present_JJ study_NN ,_, 7_CD ._. 6_CD %_NN of_IN reconstructed_VBD embryos_NNS produced_VBN by_IN
        transferring_VBG confluent_NN adult_NN somatic_JJ cells_NNS into_IN enucleated_JJ
        M_NNP II_NNP oocytes_NNS matured_VBN in_IN the_DT protein-free_JJ medium_NN developed_VBN
        to_TO the_DT blastocyst_NN stage_NN ._. The_DT blastocyst_NN formation_NN rate_NN in_IN
        our_PRP$ study_NN is_VBZ similar_JJ to_TO results_NNS from_IN the_DT recent_JJ reports_NNS in_IN
        which_WDT porcine_NN adult_NN somatic_JJ (_( cumulus_JJ )_) cells_NNS (_( 5_CD -_: 10_CD %_NN )_) [_NN 29_CD ,_,
        51_CD ]_NN or_CC fetal_JJ fibroblasts_NNS (_( 1_CD -_: 16_CD %_NN )_) [_NN 11_CD ,_, 29_CD ,_, 51_CD ,_, 52_CD ,_, 53_CD ,_, 54_CD ,_,
        55_CD ,_, 56_CD ,_, 57_CD ]_NN were_VBD transferred_VBN into_IN enucleated_JJ M_NNP II_NNP oocytes_NNS
        matured_VBN in_IN media_NNS supplemented_JJ with_IN pFF_NN ._. In_IN addition_NN ,_,
        quality_NN of_IN the_DT blastocysts_NNS based_VBN on_IN the_DT mean_JJ number_NN of_IN
        cells_NNS (_( 45_CD ._. 1_LS cells_NNS )_) equals_VBZ if_IN not_RB exceeds_VBZ results_NNS from_IN
        previous_JJ studies_NNS (_( cumulus_JJ cells_NNS :_: 28_CD ._. 9_CD cells_NNS [_NN 51_CD ]_NN ;_: fetal_JJ
        fibroblasts_NNS :_: 12_CD ._. 5_LS -_: 66_CD ._. 0_CD cells_NNS [_NN 11_CD ,_, 51_CD ,_, 52_CD ,_, 53_CD ,_, 54_CD ,_, 55_CD ,_,
        56_CD ]_NN )_) ._. Although_IN this_DT study_NN did_VBD not_RB compare_VB defined_VBN IVM_NNP
        medium_NN with_IN complex_JJ medium_NN the_DT results_NNS indicate_VBP that_IN
        protein-free_JJ IVM_NNP medium_NN is_VBZ suitable_JJ for_IN maturing_VBG recipient_JJ
        oocytes_NNS for_IN the_DT production_NN of_IN cloned_VBN embryos_NNS ._. The_DT defined_VBN
        conditions_NNS will_MD allow_VB us_PRP to_TO examine_VB factors_NNS affecting_VBG
        nuclear_JJ reprogramming_VBG of_IN reconstructed_VBD embryos_NNS more_RBR
        precisely_RB and_CC better_JJR understand_VB the_DT basic_JJ molecular_JJ
        mechanisms_NNS of_IN the_DT process_NN ._.
      
      
        Conclusions_NNP
        We_PRP have_VBP shown_VBN that_DT porcine_NN M_NNP I_PRP oocytes_NNS have_VBP a_DT potential_NN
        to_TO develop_VB into_IN blastocysts_NNS after_IN nuclear_JJ transfer_NN of_IN
        somatic_JJ cells_NNS ._. However_RB ,_, the_DT process_NN of_IN nuclear_JJ
        reprogramming_VBG may_MD be_VB different_JJ between_IN M_NNP I_PRP and_CC M_NNP II_NNP oocytes_NNS
        because_IN developmental_NN abilities_NNS of_IN reconstructed_VBD embryos_NNS
        vary_VBP between_IN the_DT maturation_NN stages_NNS of_IN recipient_JJ oocytes_NNS ._.
        Comparison_NNP of_IN reprogramming_VBG events_NNS between_IN M_NNP I_PRP and_CC M_NNP II_NNP
        oocytes_NNS would_MD bring_VB about_IN important_JJ information_NN to_TO
        understand_VB the_DT mechanisms_NNS of_IN nuclear_JJ reprogramming_VBG in_IN
        reconstructed_VBD embryos_NNS ._. The_DT use_NN of_IN defined_VBN IVM_NNP medium_NN will_MD
        be_VB useful_JJ for_IN these_DT studies_NNS ._. Taken_VBN together_RB ,_, the_DT use_NN of_IN a_DT
        defined_VBN medium_NN and_CC optimal_NN reprogramming_VBG conditions_NNS such_JJ as_IN
        the_DT type_NN of_IN donor_NN nuclei_NN and_CC recipient_JJ oocyte_NN will_MD lead_VB to_TO
        improvements_NNS in_IN porcine_NN cloning_VBG outcomes_NNS ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          Donor_NNP Cells_NNP
          Porcine_NNP fibroblasts_NNS were_VBD harvested_VBN from_IN an_DT ear_NN skin_NN
          biopsy_NN obtained_VBN from_IN an_DT adult_NN pig_NN ._. The_DT tissue_NN was_VBD finely_RB
          minced_JJ and_CC digested_VBN in_IN 0_CD ._. 125_CD %_NN (_( w_NN /_NN v_NN )_) trypsin_NN /_NN 0_CD ._. 02_CD %_NN (_( w_NN /_NN v_NN )_)
          EDTA_NNP solution_NN (_( Sigma_NNP Chemical_NNP Co_NNP ._. ,_, St_NNP ._. Louis_NNP ,_, MO_NNP )_)
          containing_VBG 1_CD mg_NN /_NN ml_NN collagenase_NN (_( Sigma_NNP )_) and_CC 0_CD ._. 3_CD mg_NN /_NN ml_NN
          hyaluronidase_NN (_( Sigma_NNP )_) for_IN 2_CD h_NN at_IN 37_CD °_NN C_NNP ._. After_IN digestion_NN ,_,
          the_DT mixture_NN was_VBD filtered_VBN through_IN four_CD layers_NNS of_IN sterile_JJ
          gauze_NN and_CC cells_NNS were_VBD pelleted_JJ by_IN centrifugation_NN ._. Cells_NNP
          were_VBD cultured_JJ in_IN DMEM_NNP /_NN F-_NNP 12_CD medium_NN (_( Sigma_NNP )_) supplemented_JJ
          with_IN 20_CD %_NN (_( v_NN /_NN v_NN )_) FCS_NNP (_( Biowhittaker_NNP Inc_NNP ._. ,_, Walkersville_NNP ,_, MD_NNP )_)
          under_IN 5_CD %_NN CO_NNP 
          2_CD in_IN air_NN at_IN 37_CD °_NN C_NNP ._. After_IN reaching_VBG
          confluence_NN ,_, cells_NNS were_VBD passaged_JJ ._. Passage_NNP 2_CD fibroblasts_NNS
          were_VBD trypsinized_JJ ,_, suspended_VBN in_IN the_DT culture_NN medium_NN with_IN
          10_CD %_NN (_( v_NN /_NN v_NN )_) dimethyl_NN sulfoxide_NN (_( Sigma_NNP )_) and_CC stored_VBD as_IN frozen_VBN
          aliquots_NNS ._. Donor_NNP cells_NNS were_VBD used_VBN for_IN nuclear_JJ transfer_NN
          between_IN passages_NNS 3_CD and_CC 9_CD of_IN culture_NN ._. For_IN preparation_NN of_IN
          donors_NNS in_IN G_NNP 0_CD /_NN G_NNP 1_CD phase_NN ,_, the_DT cells_NNS were_VBD allowed_VBN to_TO grow_VB to_TO
          confluency_NN by_IN culturing_VBG for_IN 6_CD days_NNS and_CC a_DT single_JJ cell_NN
          suspension_NN was_VBD prepared_VBN by_IN standard_JJ trypsinization_NN ._. The_DT
          cells_NNS were_VBD used_VBN for_IN nuclear_JJ transfer_NN within_IN 5_CD days_NNS after_IN
          reaching_VBG confluence_NN ._. After_IN 2_CD -_: 4_CD days_NNS of_IN subculturing_VBG ,_, the_DT
          cells_NNS (_( approximately_RB 50_CD %_NN of_IN confluency_NN )_) were_VBD cultured_JJ in_IN
          the_DT medium_NN supplemented_JJ with_IN 0_CD ._. 3_CD μg_NN /_NN ml_NN nocodazole_NN
          (_( Sigma_NNP )_) ,_, a_DT microtubule_NN polymerization_NN inhibitor_NN ,_, for_IN 10_CD h_NN
          to_TO induce_VB G_NNP 2_CD /_NN M_NNP phase_NN arrest_NN ._. After_IN gentle_JJ pipetting_VBG ,_,
          cells_NNS floating_VBG in_IN the_DT medium_NN were_VBD collected_VBN ._. Both_DT donor_NN
          cells_NNS were_VBD prepared_VBN immediately_RB prior_RB to_TO nuclear_JJ
          transfer_NN ._.
        
        
          Recipient_NNP Oocytes_NNP
          Ovaries_NNP were_VBD collected_VBN from_IN a_DT local_JJ slaughterhouse_NN and_CC
          transported_VBN in_IN 0_CD ._. 9_CD %_NN saline_NN at_IN approximately_RB 32_CD °_NN C_NNP ._.
          Follicles_NNP greater_JJR than_IN 3_CD mm_NN in_IN diameter_NN were_VBD aspirated_JJ
          with_IN an_DT 18_CD -_: gauge_VB needle_NN using_VBG vacuum_NN suction_NN (_( 100_CD mmHg_NN ;_:
          28_CD ml_NN /_NN min_NN )_) ._. Aspirated_NNP oocytes_NNS that_WDT had_VBD an_DT evenly_RB
          granulated_JJ cytoplasm_NN and_CC were_VBD surrounded_VBN by_IN at_IN least_JJS two_CD
          uniform_NN layers_NNS of_IN compact_JJ cumulus_JJ cells_NNS were_VBD selected_VBN and_CC
          washed_VBN three_CD times_NNS in_IN Hepes-buffered_NNP synthetic_JJ oviductal_NN
          fluid_JJ medium_NN [_NN 58_CD ]_NN ._. Oocytes_NNP were_VBD transferred_VBN into_IN tubes_NNS
          containing_VBG Hepes-buffered_NNP TCM-_NNP 199_CD (_( Gibco_NNP BRL_NNP ,_, Grand_NNP
          Island_NNP ,_, NY_NNP )_) supplemented_JJ with_IN 0_CD ._. 57_CD mM_NN cysteine_NN ,_, 10_CD ng_NN /_NN ml_NN
          epidermal_NN growth_NN factor_NN (_( Sigma_NNP )_) ,_, 100_CD IU_NNP /_NN ml_NN penicillin_NN ,_,
          100_CD μg_NN /_NN ml_NN streptomycin_NN ,_, 0_CD ._. 25_CD ng_NN /_NN ml_NN amphotericin_NN ,_, 0_CD ._. 01_CD
          IU_NNP /_NN ml_NN porcine_NN FSH_NNP (_( Sioux_NNP Biochemicals_NNP ,_, Sioux_NNP Center_NNP ,_, IA_NNP )_) ,_,
          0_CD ._. 01_CD IU_NNP /_NN ml_NN porcine_NN LH_NNP (_( Sioux_NNP Biochemicals_NNP )_) and_CC 0_CD ._. 1_CD %_NN (_( w_NN :_: v_NN )_)
          polyvinyl_NN alcohol_NN (_( maturation_NN medium_NN )_) [_NN 50_CD ]_NN ,_, and_CC shipped_VBD
          to_TO the_DT laboratory_NN overnight_JJ (_( 20_CD -_: 24_CD h_NN )_) at_IN 38_CD ._. 5_LS °_NN C_NNP ._. Oocytes_NNP
          continued_VBD to_TO be_VB cultured_JJ in_IN the_DT tubes_NNS under_IN 38_CD ._. 5_LS °_NN C_NNP until_IN
          enucleation_NN ._.
        
        
          Nuclear_JJ Transfer_NN
          Reconstructed_NNP embryos_NNS were_VBD produced_VBN using_VBG a_DT
          modification_NN of_IN the_DT method_NN described_VBN by_IN Miyoshi_NNP et_CC al_NN ._. [_NN
          44_CD ]_NN ._. Cumulus_NNP cells_NNS were_VBD removed_VBN by_IN vortexing_VBG with_IN 0_CD ._. 1_CD %_NN
          (_( w_NN :_: v_NN )_) hyaluronidase_NN and_CC denuded_JJ oocytes_NNS were_VBD transferred_VBN
          into_IN 100_CD μl_NN of_IN Hepes-buffered_NNP TCM-_NNP 199_CD supplemented_JJ with_IN
          7_CD ._. 5_CD μg_NN /_NN ml_NN cytochalasin_NN B_NNP (_( Sigma_NNP )_) and_CC 10_CD %_NN FCS_NNP with_IN the_DT
          osmolarity_NN adjusted_VBN to_TO 300_CD mOsm_NN by_IN adding_VBG sorbitol_NN
          (_( manipulation_NN medium_NN )_) at_IN 29_CD or_CC 42_CD h_NN after_IN IVM_NNP ._. The_DT M_NNP I_PRP
          plate_NN or_CC the_DT first_JJ polar_JJ body_NN and_CC M_NNP II_NNP plate_NN were_VBD removed_VBN
          by_IN aspiration_NN with_IN a_DT 15_CD -_: μm_NN inner_JJ diameter_NN glass_NN pipette_NN ._.
          The_DT oocytes_NNS had_VBD been_VBN previously_RB stained_JJ in_IN the_DT
          manipulation_NN medium_NN supplemented_JJ with_IN 5_CD μg_NN /_NN ml_NN Hoechst_NNP
          33342_CD (_( Sigma_NNP )_) for_IN 20_CD min_NN and_CC confirmation_NN of_IN successful_JJ
          enucleation_NN was_VBD achieved_VBN by_IN visualizing_VBG the_DT cytoplast_NN and_CC
          removed_VBN cytoplasm_NN under_IN ultraviolet_NN light_JJ ._. After_IN
          enucleation_NN ,_, a_DT donor_NN cell_NN was_VBD inserted_VBN into_IN the_DT
          perivitelline_NN space_NN of_IN each_DT enucleated_JJ oocyte_NN using_VBG the_DT
          same_JJ glass_NN pipette_NN ._. When_WRB nocodazole-treated_JJ cells_NNS were_VBD
          used_VBN as_IN donors_NNS ,_, large_JJ cells_NNS (_( cell_NN diameter_NN was_VBD >_NN 15_CD μm_NN )_)
          were_VBD selected_VBN ._. In_IN our_PRP$ preliminary_JJ experiment_NN ,_, such_JJ a_DT
          relatively_RB large_JJ cytoplasmic_JJ volume_NN was_VBD typical_JJ of_IN cells_NNS
          at_IN the_DT G_NNP 2_CD /_NN M_NNP phase_NN as_IN described_VBN by_IN Wakayama_NNP et_CC al_NN ._. [_NN 13_CD ]_NN ._.
          Cell-oocyte_NNP complexes_NNS were_VBD washed_VBN in_IN TCM-_NNP 199_CD supplemented_JJ
          with_IN 10_CD %_NN FCS_NNP ,_, transferred_VBN to_TO the_DT same_JJ medium_NN and_CC kept_VBD
          under_IN 5_CD %_NN CO_NNP 
          2_CD in_IN air_NN at_IN 38_CD ._. 5_LS °_NN C_NNP until_IN fusion_NN ._.
          Fusion_NNP was_VBD performed_VBN in_IN a_DT 100_CD mm_NN dish_NN filled_VBN with_IN 15_CD
          ml_NN of_IN Zimmermann_NNP fusion_NN medium_NN [_NN 59_CD ]_NN ._. Two_CD stainless_JJ steel_NN
          wires_NNS (_( 100_CD μm_NN diameter_NN )_) attached_VBN to_TO micromanipulators_NNS
          were_VBD used_VBN as_IN electrodes_NNS ._. The_DT single_JJ cell-oocyte_JJ complex_NN
          was_VBD sandwiched_VBN between_IN the_DT electrodes_NNS and_CC oriented_VBN with_IN
          the_DT contact_NN surface_NN between_IN the_DT cytoplast_NN and_CC the_DT donor_NN
          cell_NN perpendicular_NN to_TO the_DT electrodes_NNS ._. The_DT distance_NN
          between_IN the_DT electrodes_NNS was_VBD about_IN 100_CD μm_NN ._. Membrane_NNP fusion_NN
          was_VBD induced_VBN by_IN applying_VBG a_DT single_JJ direct_JJ current_JJ pulse_NN of_IN
          250_CD V_NNP /_NN mm_NN for_IN a_DT duration_NN of_IN 20_CD μsec_NN with_IN a_DT prepulse_NN of_IN
          alternating_VBG current_JJ field_NN of_IN 5_CD V_NNP ,_, 1_CD MHz_NNP for_IN 2_CD sec_NN using_VBG
          an_DT LF_NNP 101_CD Fusion_NNP Machine_NNP (_( TR_NNP Tech_NNP Co_NNP ._. ,_, Tokyo_NNP ,_, Japan_NNP )_) ._.
          Following_VBG fusion_NN ,_, the_DT complexes_NNS were_VBD washed_VBN in_IN G_NNP 1_CD ._. 2_CD
          medium_NN [_NN 60_CD ]_NN and_CC cultured_JJ for_IN a_DT period_NN of_IN 1_CD h_NN in_IN 100_CD μl_NN
          of_IN the_DT same_JJ medium_NN ._. Fusion_NNP rate_NN was_VBD then_RB determined_VBN by_IN
          microscopic_JJ examination_NN ._.
        
        
          Activation_NNP of_IN Reconstructed_NNP Embryos_NNP
          Fused_NNP embryos_NNS were_VBD washed_VBN once_RB in_IN Zimmermann_NNP fusion_NN
          medium_NN and_CC then_RB placed_VBN between_IN 2_CD wire_NN electrodes_NNS (_( 1_CD mm_NN
          apart_RB )_) of_IN the_DT fusion_NN chamber_NN slide_NN with_IN 15_CD ml_NN of_IN the_DT
          fusion_NN medium_NN ._. Direct_NNP current_JJ pulses_NNS of_IN 75_CD V_NNP /_NN mm_NN were_VBD
          applied_VBN twice_RB to_TO the_DT embryos_NNS for_IN a_DT duration_NN of_IN 60_CD μsec_NN at_IN
          intervals_NNS of_IN 5_CD sec_NN ._.
        
        
          Examination_NNP of_IN Reconstructed_NNP Embryos_NNP
          Before_IN and_CC after_IN activation_NN ,_, fused_JJ embryos_NNS were_VBD
          stained_JJ with_IN 5_CD μg_NN /_NN ml_NN Hoechst_NNP 33342_CD for_IN 20_CD min_NN and_CC then_RB
          examined_VBD for_IN nuclear_JJ swelling_VBG and_CC polar_JJ body_NN formation_NN
          under_IN ultraviolet_NN light_JJ ._. The_DT nucleus_NN with_IN a_DT diameter_NN that_WDT
          was_VBD at_IN least_JJS twice_RB bigger_JJR than_IN the_DT original_JJ size_NN of_IN donor_NN
          cell_NN nuclei_NN was_VBD considered_VBN to_TO be_VB a_DT swollen_JJ nucleus_NN ._.
        
        
          Experimental_NNP Studies_NNPS
          
            Cell_NNP Cycle_NNP Analysis_NNP of_IN Donor_NNP Cells_NNP
            In_IN Experiment_NNP 1_CD ,_, the_DT cell_NN cycle_NN stages_NNS of_IN confluent_NN
            and_CC nocodazole-treated_JJ donor_NN cells_NNS were_VBD analyzed_VBN using_VBG
            flow_NN cytometry_NN ._. Collected_NNP cells_NNS (_( approx_NN ._. 2_LS ×_NN 10_CD 6_CD cells_NNS )_)
            were_VBD centrifuged_JJ and_CC the_DT pellet_NN was_VBD re-suspended_JJ in_IN 1_CD
            ml_NN of_IN cold_JJ PBS_NNP ._. Then_RB ,_, cells_NNS were_VBD fixed_VBN by_IN adding_VBG 4_CD ml_NN
            of_IN -_: 20_CD °_NN C_NNP absolute_JJ ethanol_NN and_CC stored_VBD in_IN -_: 20_CD °_NN C_NNP ._. Before_IN
            analysis_NN ,_, cells_NNS were_VBD centrifuged_JJ and_CC the_DT pellet_NN was_VBD
            re-suspended_JJ in_IN 1_CD ml_NN of_IN PBS_NNP ._. Then_RB ,_, 100_CD μl_NN of_IN DNase-free_NNP
            RNase_NNP A_DT (_( 200_CD μg_NN /_NN ml_NN ;_: Sigma_NNP )_) was_VBD added_VBN and_CC samples_NNS were_VBD
            incubated_JJ for_IN 30_CD min_NN at_IN 37_CD °_NN C_NNP ._. After_IN incubation_NN ,_, 100_CD μl_NN
            of_IN propidium_NN iodide_NN (_( 1_CD mg_NN /_NN ml_NN ;_: Sigma_NNP )_) was_VBD added_VBN into_IN
            each_DT sample_NN and_CC cells_NNS were_VBD analyzed_VBN using_VBG FACStartPLUS_NNP
            analyzer_NN (_( Becton_NNP Dickinson_NNP ,_, San_NNP Jose_NNP ,_, CA_NNP )_) ._.
          
          
            Behavior_NNP before_IN Activation_NNP of_IN Donor_NNP Cell_NNP
            Nuclei_NNP
            In_IN Experiment_NNP 2_CD ,_, we_PRP examined_VBD the_DT behavior_NN before_IN
            activation_NN of_IN donor_NN cell_NN nuclei_NN transferred_VBN into_IN
            enucleated_JJ M_NNP I_PRP oocytes_NNS ._. M_NNP I_PRP oocytes_NNS were_VBD enucleated_JJ at_IN
            29_CD h_NN after_IN IVM_NNP and_CC confluent_NN or_CC nocodazole-treated_JJ
            cells_NNS were_VBD transferred_VBN ._. Fused_NNP embryos_NNS were_VBD cultured_JJ in_IN
            the_DT maturation_NN medium_NN for_IN 15_CD h_NN and_CC then_RB examined_VBD for_IN
            nuclear_JJ swelling_VBG and_CC polar_JJ body_NN formation_NN ._. When_WRB
            confluent_NN cells_NNS were_VBD used_VBN as_IN donors_NNS ,_, fused_JJ embryos_NNS were_VBD
            cultured_JJ in_IN the_DT medium_NN supplemented_JJ with_IN 7_CD ._. 5_CD μg_NN /_NN ml_NN
            cytochalasin_NN B_NNP to_TO prevent_VB extrusion_NN of_IN polar_JJ
            bodies_NNS ._.
          
          
            Behavior_NNP after_IN Activation_NNP of_IN Donor_NNP Cell_NNP
            Nuclei_NNP
            In_IN Experiment_NNP 3_CD ,_, the_DT behavior_NN of_IN nuclei_NN of_IN confluent_NN
            or_CC nocodazole-treated_JJ cells_NNS transferred_VBN into_IN enucleated_JJ
            M_NNP I_PRP or_CC M_NNP II_NNP oocytes_NNS was_VBD examined_VBN after_IN activation_NN ._.
            Embryos_NNP reconstituted_JJ with_IN M_NNP I_PRP oocytes_NNS were_VBD cultured_JJ in_IN
            the_DT maturation_NN medium_NN with_IN or_CC without_IN cytochalasin_NN B_NNP
            for_IN 15_CD h_NN and_CC then_RB activated_VBN ._. M_NNP II_NNP oocytes_NNS were_VBD
            enucleated_JJ at_IN 42_CD h_NN after_IN IVM_NNP and_CC embryos_NNS reconstituted_JJ
            with_IN them_PRP were_VBD activated_VBN at_IN 3_CD h_NN after_IN fusion_NN ._. Activated_NNP
            embryos_NNS were_VBD cultured_JJ in_IN 100_CD μl_NN of_IN G_NNP 1_CD ._. 2_CD medium_NN for_IN 6_CD h_NN
            and_CC then_RB examined_VBD for_IN nuclear_JJ swelling_VBG and_CC polar_JJ body_NN
            formation_NN ._. When_WRB confluent_NN cells_NNS were_VBD used_VBN as_IN donors_NNS ,_,
            embryos_NNS were_VBD cultured_JJ in_IN G_NNP 1_CD ._. 2_LS medium_NN supplemented_JJ with_IN
            7_CD ._. 5_CD μg_NN /_NN ml_NN cytochalasin_NN B_NNP for_IN 2_CD h_NN after_IN activation_NN to_TO
            prevent_VB extrusion_NN of_IN polar_JJ bodies_NNS [_NN 44_CD ]_NN ._.
          
          
            Development_NNP of_IN Reconstructed_NNP Embryos_NNP
            Experiment_NNP 4_CD was_VBD undertaken_VBN to_TO compare_VB in_IN vitro_NN
            developmental_NN abilities_NNS of_IN reconstructed_VBD embryos_NNS
            produced_VBN by_IN transferring_VBG confluent_NN or_CC
            nocodazole-treated_JJ cells_NNS into_IN enucleated_JJ M_NNP I_PRP or_CC M_NNP II_NNP
            oocytes_NNS as_IN described_VBN above_IN ._. After_IN culture_NN in_IN G_NNP 1_CD ._. 2_LS
            medium_NN for_IN 3_CD days_NNS ,_, the_DT embryos_NNS were_VBD transferred_VBN into_IN
            100_CD μl_NN of_IN G_NNP 2_CD ._. 2_LS medium_NN [_NN 60_CD ]_NN and_CC continued_VBD to_TO be_VB
            cultured_JJ ._. The_DT embryos_NNS were_VBD examined_VBN for_IN cleavage_NN and_CC
            blastocyst_NN formation_NN at_IN 2_CD and_CC 7_CD days_NNS after_IN culture_NN ,_,
            respectively_RB ._. At_IN the_DT end_NN of_IN the_DT culture_NN period_NN ,_, the_DT
            number_NN of_IN cells_NNS in_IN blastocysts_NNS was_VBD examined_VBN ._. The_DT
            blastocysts_NNS were_VBD placed_VBN on_IN slides_NNS with_IN a_DT drop_NN of_IN
            mounting_VBG medium_NN consisting_VBG of_IN glycerol_NN and_CC PBS_NNP (_( 9_CD :_: 1_LS )_)
            containing_VBG 0_CD ._. 1_CD mg_NN /_NN ml_NN Hoechst_NNP 33342_CD ._. A_DT cover_NN slip_NN was_VBD
            placed_VBN on_IN the_DT top_NN of_IN the_DT blastocysts_NNS and_CC the_DT edge_NN was_VBD
            sealed_VBN with_IN fingernail_NN polish_NN ._. The_DT numbers_NNS of_IN nuclei_NN
            were_VBD counted_VBN under_IN ultraviolet_NN light_JJ ._.
          
        
        
          Statistical_NNP Analysis_NNP
          All_DT percentage_NN data_NN were_VBD subjected_VBN to_TO an_DT arcsin_NN square_JJ
          root_NN transformation_NN in_IN each_DT replicate_VB and_CC the_DT transformed_VBN
          values_NNS were_VBD analyzed_VBN using_VBG one-way_JJ (_( Experiment_NNP 2_LS )_) or_CC
          two-way_JJ (_( Experiments_NNS 3_CD and_CC 4_LS )_) ANOVA_NNP followed_VBN by_IN
          Student-_NNP Newman-_NNP Keuls_NNP test_NN ._. The_DT numbers_NNS of_IN cells_NNS in_IN
          blastocysts_NNS were_VBD analyzed_VBN using_VBG Student_NNP t-test_JJ ._. A_DT
          probability_NN of_IN P_NN <_NN 0_CD ._. 05_CD was_VBD considered_VBN statistically_RB
          significant_JJ ._.
        
      
    
  
